Last deal

$2.M

Amount

Seed

Stage

09.06.2014

Date

3

all rounds

$5.M

Total amount

General

About Company
Axonia Medical uses tissue-engineered nerve grafts to repair and restore damaged nervous systems.

Industry

Sector :

Subsector :

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The company's technology involves harvesting cell bodies with living axons from organ donors, stretching them to the desired length, and using them to repair severed or damaged peripheral nerves. This innovative approach aims to achieve levels of functional recovery not possible with current technologies and is expected to be indicated for surgical reconstruction of major peripheral nerve injuries. Axonia Medical's goal is to rebuild and restore damaged nervous systems using tissue-engineered nerve grafts.
Contacts